Literature DB >> 22542531

Cancer chemotherapy: a critical analysis of its 60 years of history.

Darío Galmarini1, Carlos M Galmarini, Felipe C Galmarini.   

Abstract

Chemotherapy has already proven widely effective in the treatment of cancer, occupying a prominent place in the current therapeutic arsenal. However, in recent years, there has been a plateau in the evolution of the clinical results obtained with this modality treatment. In some cases, the limitations of chemotherapy observed during the early days still apply. These facts forced us to do a thorough analysis of what happened in the past 60years. We have observed that each major advance obtained in this field was based on empirical clinical observations. We thus believe that the current results of old or new agents can only be improved by understanding the natural history of each specific cancer subtype at the clinical level and by overcoming the physiological barriers involved in chemotherapy failure. This strategy will surely allow us to enlarge the list of curable cancers by chemotherapy.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542531     DOI: 10.1016/j.critrevonc.2012.03.002

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  24 in total

Review 1.  A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy.

Authors:  Pravin T P Kaumaya
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Treatment effect of low intensity pulsed ultrasound on leukopenia induced by cyclophosphamide in rabbits.

Authors:  Baoru Liu; Yueping Luo; Dong Luo; Weichen Zhou; Yu Zhang; Ruixin He; Junshu Li; Yong Wang; Yan Wang; Wenzhi Chen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 3.  Survivorship in untreated breast cancer patients.

Authors:  Carlos M Galmarini; Olivier Tredan; Felipe C Galmarini
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

4.  Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.

Authors:  Mar Creixell; Nicholas A Peppas
Journal:  Nano Today       Date:  2012-08-01       Impact factor: 20.722

5.  Non-Cytotoxic Sulfated Heterorhamnan from Gayralia brasiliensis Green Seaweed Reduces Driver Features of Melanoma Metastatic Progression.

Authors:  D L Bellan; E Mazepa; S M P Biscaia; J P Gonçalves; C C Oliveira; G R Rossi; L G Ferreira; M D Noseda; E S Trindade; M E R Duarte; C R C Franco
Journal:  Mar Biotechnol (NY)       Date:  2020-01-22       Impact factor: 3.619

6.  Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations.

Authors:  Ashley J Mulford; Claudia Wing; M Eileen Dolan; Heather E Wheeler
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

Review 7.  Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review.

Authors:  Michael Retsky; Romano Demicheli; William J M Hrushesky; Patrice Forget; Marc De Kock; Isaac Gukas; Rick A Rogers; Michael Baum; Vikas Sukhatme; Jayant S Vaidya
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel.

Authors:  Tianyuan Ci; Liang Chen; Lin Yu; Jiandong Ding
Journal:  Sci Rep       Date:  2014-07-01       Impact factor: 4.379

9.  Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.

Authors:  Philip Savage
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

10.  Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest.

Authors:  S Raz; D Sheban; N Gonen; M Stark; B Berman; Y G Assaraf
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.